Budapest, Hungary

Andras Bilkei Gorzo

This inventor holds 1 USPTO granted patent. Top assignee: Egis Gyogyszergyar Rt.. Active years: 2000.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andras Bilkei Gorzo. Retrieved from https://idiyas.com/inventor/andras-bilkei-gorzo-tml67uvb

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 13.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2000

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Andras Bilkei Gorzo: Innovator in Anxiolytic Agents

Introduction

Andras Bilkei Gorzo is a prominent inventor based in Budapest, Hungary. He has made a notable contribution to the field of pharmaceuticals, particularly with his innovative approach to anxiolytic agents. His work is recognized through his patent, which highlights his commitment to advancing medical science.

Latest Patents

Andras holds a patent for "1,7,7-trimethyl-bicyclo[2.2.1]heptane derivatives as anxiolytic agents." This invention underscores his expertise in developing compounds that may offer new avenues for anxiety treatment, marking a significant achievement in his career.

Career Highlights

Currently, Andras is affiliated with Egis Gyógyszergyár Rt., where he continues to apply his scientific knowledge to the development of effective medicinal solutions. His dedication to research and development has been a cornerstone of his professional journey.

Collaborations

Andras collaborates with skilled professionals in his field, including notable coworkers such as Istvan Gacsalyi and Imre Klebovich. These collaborations exemplify the collective effort to push the boundaries of innovation in pharmaceutical research.

Conclusion

In conclusion, Andras Bilkei Gorzo is a distinguished inventor whose contributions to anxiolytic agents are recognized in the pharmaceutical industry. His patent reflects a significant advancement in the treatment of anxiety, demonstrating the importance of continued innovation and collaboration in enhancing health outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…